Effects of serum on C3b-stimulated release of prostaglandins and thromboxane B2 from human monocytes
- 31 October 1984
- journal article
- Published by Elsevier in Immunopharmacology
- Vol. 8 (2) , 79-89
- https://doi.org/10.1016/0162-3109(84)90046-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Prostaglandin synthesis inhibition by maternal and fetal sheep plasma and its relation to haptoglobin and albumin levelsProstaglandins and Medicine, 1981
- Pathophysiological states modify levels in rat plasma of factors which inhibit synthesis and enhance breakdown of PGNature, 1980
- Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes.The Journal of Experimental Medicine, 1980
- Transferrin can replace serum for in vitro growth of mitogen‐stimulated T lymphocytesEuropean Journal of Immunology, 1979
- Effect of serum on prostaglandin production during the co‐culture of human thyroid cells and peripheral blood mononuclear cellsJournal of Cellular Physiology, 1979
- Endogenous inhibitor of prostaglandin synthetaseNature, 1977
- Serum albumin is essential for in vitro growth of activated human lymphocytes.The Journal of Experimental Medicine, 1975
- The effects of human serum fractions on phytohemagglutinin- and concanavalin A-stimulated human lymphocyte culturesCellular Immunology, 1972
- ISOLATION OF A FRAGMENT (C3a) OF THE THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUMThe Journal of Experimental Medicine, 1969
- LYMPHOCYTE TRANSFORMATION IN MULTIPLE SCLEROSIS: Inhibition of Unstimulated Thymidine Uptake by a Serum FactorThe Lancet, 1968